- Home
- INM vs FTAIM Comparison
INM vs FTAIM Comparison
Compare INM & FTAIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
FTAIM
FTAI Aviation Ltd. 9.500% Fixed-Rate Reset Series D Cumulative Perpetual Redeemable Preferred Shares
Current Price
Company Overview
Basic Information| Metric | INM | FTAIM |
|---|---|---|
| Founded | 1981 | N/A |
| Country | Canada | United States |
| Employees | N/A | 580 |
| Industry | Biotechnology: Pharmaceutical Preparations | Misc Corporate Leasing Services |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7M | N/A |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | INM | FTAIM |
|---|---|---|
| Price | $1.27 | $26.95 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 893.9K | N/A |
| Earning Date | 11-06-2025 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,798,116.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.13 | N/A |
| 52 Week High | $8.27 | N/A |
Technical Indicators
Market Signals| Indicator | INM | FTAIM |
|---|---|---|
| Relative Strength Index (RSI) | 39.58 | 54.45 |
| Support Level | $1.16 | $26.80 |
| Resistance Level | $1.48 | $26.91 |
| Average True Range (ATR) | 0.11 | 0.10 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 30.56 | 71.43 |
Price Performance
Historical ComparisonAbout INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.
About FTAIM FTAI Aviation Ltd. 9.500% Fixed-Rate Reset Series D Cumulative Perpetual Redeemable Preferred Shares
FTAI Aviation Ltd is an aerospace company. It owns and maintains commercial jet engines with a focus on CFM56 engines. FTAI owns and leases jet aircraft, which often facilitates the acquisition of engines at attractive prices. It invests in aviation assets and aerospace products that generate stable cash flows with the potential for earnings growth and asset appreciation.